Acadia Healthcare (NASDAQ:ACHC) Given New $20.00 Price Target at Barclays

Key Points

• Barclays has reduced its price target for Acadia Healthcare from $28.00 to $20.00, maintaining an "equal weight" rating, which suggests a potential upside of 10.41% from its current price.
• Other analysts have also adjusted their price targets, with Mizuho cutting its target from $37.00 to $32.00 and KeyCorp lowering theirs from $65.00 to $55.00, while overall analyst consensus rates the stock as a "Moderate Buy" with an average target of $47.06.
• Acadia Healthcare recently reported a quarterly EPS of $0.83, exceeding estimates and reflecting a 9.2% year-over-year revenue growth to $869.23 million.

Acadia Healthcare (NASDAQ:ACHC - Free Report) had its target price reduced by Barclays from $28.00 to $20.00 in a research report released on Thursday,Benzinga reports. They currently have an equal weight rating on the stock.

Several other brokerages have also recently weighed in on ACHC. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Mizuho cut their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. KeyCorp decreased their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Stephens upgraded Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Guggenheim assumed coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $44.75.

Acadia Healthcare Trading Down 1.3%

NASDAQ ACHC traded down $0.25 on Thursday, hitting $18.99. 1,501,645 shares of the company were exchanged, compared to its average volume of 2,185,156. The firm has a market capitalization of $1.75 billion, a P/E ratio of 12.60, a price-to-earnings-growth ratio of 3.74 and a beta of 0.88. The company's 50 day moving average price is $22.18 and its 200-day moving average price is $27.65. Acadia Healthcare has a twelve month low of $17.13 and a twelve month high of $82.40. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. Acadia Healthcare's revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 earnings per share. Analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several large investors have recently bought and sold shares of ACHC. FMR LLC lifted its position in Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Acadia Healthcare by 18.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock worth $126,189,000 after buying an additional 486,395 shares in the last quarter. Hawk Ridge Capital Management LP raised its stake in Acadia Healthcare by 437.5% in the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock valued at $74,988,000 after purchasing an additional 2,013,126 shares in the last quarter. Citigroup Inc. grew its position in Acadia Healthcare by 5,144.2% in the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock valued at $72,047,000 after acquiring an additional 2,330,898 shares during the last quarter. Finally, Maverick Capital Ltd. grew its holdings in shares of Acadia Healthcare by 116.3% during the first quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company's stock worth $68,127,000 after purchasing an additional 1,208,296 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.